Answers are grounded in this paper and cite their sources.
Experiments in monkeys have demonstrated that the chronic vasospasm and arterial injury reaction produced by subarachnoid blood injection can be prevented by treatment with the phosphodiesterase inhibitor phthalazinol. This protective effect, which is present even when the drug treatment is initiated after the subarachnoid blood injection, is presumed to occur because of the platelet inhibiting effect of phthalazinol.
No takes yet. Share an insight, caveat, or question.
Alksne et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: